Showing results (61-70 of 257) with videos related to
Sort By:
Pageof 26
Histopathology|June 30, 2015
Differential expression of immunohistochemical markers in primary lung and breast cancers enriched for triple-negative tumoursElena Provenzano, David J Byrne, Prudence A Russell, et al.Immunotherapy|December 22, 2016
Is still there a role for IL-2 for solid tumors other than melanoma or renal cancer?Giandomenico Roviello, Laura Zanotti, Pierpaolo Correale, et al.European Journal of Cancer (Oxford, England : 1990)|March 1, 2017
The role of bevacizumab in solid tumours: A literature based meta-analysis of randomised trialsGiandomenico Roviello, Thomas Bachelot, Clifford A Hudis, et al.European Journal of Cancer (Oxford, England : 1990)|October 23, 2017
Response rate as a potential surrogate for survival and efficacy in patients treated with novel immune checkpoint inhibitors: A meta-regression of randomised prospective studiesGiandomenico Roviello, Fabrice Andre, Sergio Venturini, et al.Updates in Surgery|January 23, 2020
Colorectal cancer-screening program improves both short- and long-term outcomes: a single-center experience in TriestePasquale Losurdo, Massimo Giacca, Alan Biloslavo, et al.Anti-Cancer Drugs|January 28, 2026
The good, the bad, and the manageable: real-world outcomes with CDK4/6 inhibitorsAlexandra Paulet, Silvia Mancini, Martina Catalano, et al.Journal of Cellular Biochemistry|January 19, 2018
The prognostic value of PI3K mutational status in breast cancer: A meta-analysisNavid Sobhani, Giandomenico Roviello, Silvia P Corona, et al.Clinical Genitourinary Cancer|October 4, 2016
Low-Dose Oral Ethinylestradiol With Concomitant Low-Dose Acetylsalicylic Acid for Advanced Castrate-Resistant Prostate CancerGiandomenico Roviello, Laura Zanotti, Angela Gobbi, et al.Cancer Investigation|February 7, 2017
Targeting VEGFR-2 in Metastatic Gastric Cancer: Results From a Literature-Based Meta-AnalysisGiandomenico Roviello, Karol Polom, Franco Roviello, et al.Future Oncology (London, England)|November 11, 2017
Could gonadotropin-releasing hormone analogs be helpful in the treatment of triple-negative breast cancer?Silvia Paola Corona, Giandomenico Roviello, Carla Strina, et al.Pageof 26